In:

Interim guidance - World Health Organization

Date:

25 February 2016

Guillain-Barré syndrome (GBS) is a disorder in which the body’s own immune system attacks part of the peripheral infections, including dengue and chikungunya viruses.  The syndrome can affect the peripheral nerves that control muscle strength as well as those that transmit feelings of pain, temperature and touch. This can result in muscle weakness and loss of sensation in the legs and/or arms. Approximately 25% of GBS patients require intensive care and 3-5% die even with appropriate supportive care, due to complications related to: paralysis of the muscles that control breathing; cardiac arrest; or blood clots (1).

Download full publication: